Published Clinical Study Shows Reduced Opioid Use in TKA Patients | NeuroCuple®

Clinical Evidence · Published Research · Orthopedic Recovery

Published Clinical Study Evaluates NeuroCuple® Technology in Total Knee Arthroplasty Patients

A published peer-reviewed study evaluated a nanotechnology-based pain relief device in post-operative total knee arthroplasty patients, examining pain outcomes and opioid utilization during recovery.

Why This Study Matters

Pain following orthopedic surgery remains a major clinical challenge worldwide. Total knee arthroplasty (TKA) patients often experience substantial post-operative discomfort, which can increase dependence on opioid medications during recovery.


As healthcare systems seek safer, scalable, and non-drug approaches to pain management, studies evaluating alternative technologies are becoming increasingly important.


This study contributes to the growing body of evidence exploring NeuroCuple® a reusable, drug-free pain management approaches in clinical environments.

Study Overview

The study evaluated NeuroCuple® a nanotechnology-based pain relief device in patients recovering from total knee arthroplasty surgery.

  • Post-operative orthopedic recovery setting
  • Total knee arthroplasty (TKA) patient population
  • Evaluation of pain-related outcomes
  • Evaluation of opioid utilization during recovery
  • Published in The Journal of Arthroplasty
  • Peer-reviewed clinical publication
View Published Study

Understanding the Clinical Focus

Total knee arthroplasty is one of the most common orthopedic procedures performed globally. Recovery often requires a combination of rehabilitation, mobility support, and pain management.


Traditional pain management strategies frequently rely on pharmaceutical interventions, including opioid medications. While opioids can provide meaningful pain control, long-term reliance and widespread utilization have created significant healthcare concerns globally.


This has increased interest in technologies and approaches that may help support pain management while reducing pharmaceutical burden.

Post-Operative Pain Management Orthopedic recovery can involve substantial pain during rehabilitation and early mobility restoration.
Opioid Reduction Interest Healthcare systems increasingly seek approaches that may help reduce reliance on opioid medications during recovery.
Scalable Non-Drug Approaches Reusable technologies may provide broader accessibility without continuous pharmaceutical supply requirements.
Real-World Healthcare Relevance Orthopedic recovery pathways represent a major opportunity for evaluating scalable pain support strategies.

Published in the Journal of Arthroplasty

The study was published in The Journal of Arthroplasty, a leading orthopedic publication focused on joint replacement and surgical outcomes.

Peer-reviewed publication is an important step in building scientific and clinical credibility because studies undergo independent evaluation prior to publication.

Published clinical evidence is essential for advancing new categories of scalable, drug-free pain management technologies.

Connection to the Broader Global Pain Challenge

Pain-related conditions remain one of the leading causes of disability worldwide, affecting workforce participation, healthcare utilization, recovery outcomes, and quality of life.


Scalable approaches that can function without drugs, electricity, consumables, or complex infrastructure may become increasingly important in both clinical and low-resource environments.


This is especially relevant for:

  • Post-operative recovery programs
  • Healthcare systems under strain
  • Low-resource clinical environments
  • Community-based recovery support
  • Distributed public health models
  • Drug-free pain management initiatives

NeuroCuple® and the Emerging Category of Passive Bioelectrical Interfaces

NeuroCuple® technology is described as a passive, non-powered bioelectrical interface designed to interact with the body’s local bioelectrical environment associated with pain perception through passive capacitive coupling.


Unlike powered stimulation systems, the technology does not deliver electrical stimulation, pharmaceuticals, heat, or vibration.


The reusable and non-powered nature of the platform makes it particularly relevant for scalable deployment models, including healthcare systems, humanitarian programs, and distributed community-based access.

Explore Clinical Evidence & Research

Read the Full Published Study

The complete peer-reviewed publication is available through ScienceDirect.

Access the Published Study
REMOVE THE PAIN UNLEASH THE POSSIBILITIES®